Citations 7

Transthyretin as Potential Biomarker for C9ORF72 -related Diseases (S33.001)

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.s33.001

Clinicopathologic phenotypes of four cases with MAPT P301L mutation (P2.164)

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.p2.164

The novel p.K317N mutation in MAPT gene with clinicopathological phenotype of globular glial tauopathy (P2.161)

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.p2.161

Pick's disease caused by a novel MAPT mutation (P1.216)

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.p1.216

Transthyretin as Potential Biomarker for C9ORF72 -related Diseases (I8-2A)

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.i8-2a

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

Neurology | September 12, 2013 | Volume: 81 | Issue: 15 | Pages: 1332-1341

10.1212/wnl.0b013e3182a8250c | PMID 24027057

C9ORF72 hexanucleotide repeat expansions in patients with ALS from the Coriell Cell Repository

Neurology | July 20, 2012 | Volume: 79 | Issue: 5 | Pages: 482-483

10.1212/wnl.0b013e31826170f1 | PMID 22815561